
-
N4-羟基胞苷
NMR and HPLC COA下载 MSDS下载 - Names:
N4-Hydroxycytidine
- CAS号:
3258-02-4
MDL Number: - MF(分子式): C3D11PV2O4 MW(分子量): 259.0804352
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
---|---|---|---|---|---|---|---|---|
HCQ000013-1kg | 1kg | 98.36% | ¥ 0.00 | ¥ 0.00 | Get quote | ¥ 0.00 | ||
HCQ000013-100mg | 100mg | 98.36% | ¥ 18000.00 | ¥ 18000.00 | Instock | ¥ 0.00 | ||
HCQ000013-50mg | 50mg | 98.36% | ¥ 13200.00 | ¥ 13200.00 | Instock | ¥ 0.00 | ||
HCQ000013-25mg | 25mg | 98.36% | ¥ 7920.00 | ¥ 7920.00 | Instock | ¥ 0.00 | ||
HCQ000013-10mg | 10mg | 98.36% | ¥ 4400.00 | ¥ 4400.00 | Instock | ¥ 0.00 | ||
HCQ000013-5mg | 5mg | 98.36% | ¥ 2800.00 | ¥ 2800.00 | Instock | ¥ 0.00 | ||
HCQ000013-1mg | 1mg | 98.36% | ¥ 960.00 | ¥ 960.00 | Instock | ¥ 0.00 |
中文别名 | N4-羟基胞苷;4-N-羟基胞苷; β-D-N-4-羟基胞苷; β-D-N4-羟基胞苷; N(4)-羟基胞苷; NHC; 尿苷,4-肟; β-D-N4-羟基胞苷 |
英文别名 | 4-N-Hydroxycytidine; beta-D-N-4-Hydroxycytidine; Beta-D-N4-hydroxycytidine; N(4)-Hydroxycytidine; NHC; Uridine, 4-oxime; β-D-N4-hydroxycytidine;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(hydroxyamino)-1,2-dihydropyrimidin-2-one |
CAS号 | 3258-02-4 |
SMILES | OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(NO)=NC1=O |
Inchi | InChI=1S/C9H13N3O6/c13-3-4-6(14)7(15)8(18-4)12-2-1-5(11-17)10-9(12)16/h1-2,4,6-8,13-15,17H,3H2,(H,10,11,16)/t4-,6-,7-,8-/m1/s1 |
InchiKey | XCUAIINAJCDIPM-XVFCMESISA-N |
分子式 Molecular Weight | C3D11PV2O4 |
分子量 Formula | 259.0804352 |
闪点 FP | 302.2±32.9 °C |
熔点 Melting point | NA |
沸点 Boiling point | 576.1±60.0 °C at 760 mmHg |
Polarizability极化度 | 21.7±0.5 10-24cm3 |
密度 Density | 1.9±0.1 g/cm3 |
蒸汽压 Vapor Pressure | 0.0±3.6 mmHg at 25°C |
溶解度Solubility | Water Solubility,34.4 mg/mL; |
性状 | 固体粉末,Powder |
储藏条件 Storage conditions | Store at -4℃ |
Stock Solutions of N4-Hydroxycytidine | |||
Concentration\Solvent\Mass | 1mg | 5mg | 10mg |
1 mM | 3.8577 mL | 19.2886 mL | 38.5773 mL |
5mM | 0.7715 mL | 3.8577 mL | 7.7155 mL |
10mM | 0.3858 mL | 1.9289 mL | 3.8577 mL |
DMSO:250 mg / mL(964.43 mM;需要超声);Water Solubility :34.4 mg/mL |
产品说明 | A cytidine analog being investigated to treat COVID-19. |
Introduction | N4-Hydroxyctidine, or EIDD-1931, is a ribonucleoside analog which induces mutations in RNA virions.1,2 N4-hydroxycytidine was first described in the literature in 1980 as a potent mutagen of bacteria and phage.5 It has shown antiviral activity against Venezuelan equine encephalitis virus,1 and the human coronavirus HCoV-NL63 in vitro.4 N4-hydroxycytodine has been shown to inhibit SARS-CoV-2 as well as other human and bat coronaviruses in mice and human airway epithelial cells.3 It is orally bioavailable in mice and distributes into tissue before becoming the active 5’-triphosphate form, which is incorporated into the genome of new virions, resulting in the accumulation of inactivating mutations.2 In non-human primates, N4-hydroxycytidine was poorly orally bioavailable.6 A remdesivir resistant mutant mouse hepatitis virus has also been shown to have increased sensitivity to N4-hydroxycytidine.3 The prodrug of N4-hydroxycytidine, EIDD-2801, is also being investigated for its broad spectrum activity against the coronavirus family of viruses.3 |
Application1 | 潜在冠状病毒抑制剂Experimental Unapproved Treatments for COVID-19 |
Application2 | |
Application3 |
Data regarding overdose of N4-hydroxycytidine is not readily available. The therapeutic index of N4-hydroxycytidine against a clinical isolate of SARS-CoV-2 is expected to be >100, with an in vitro IC50 of 0.3µM and a CC50 of >10µM.
Urakova N, Kuznetsova V, Crossman DK, Sokratian A, Guthrie DB, Kolykhalov AA, Lockwood MA, Natchus MG, Crowley MR, Painter GR, Frolova EI, Frolov I: beta-d-N (4)-Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome. J Virol. 2018 Jan 17;92(3). pii: JVI.01965-17. doi: 10.1128/JVI.01965-17. Print 2018 Feb 1. [PubMed:29167335] |
Painter GR, Bowen RA, Bluemling GR, DeBergh J, Edpuganti V, Gruddanti PR, Guthrie DB, Hager M, Kuiper DL, Lockwood MA, Mitchell DG, Natchus MG, Sticher ZM, Kolykhalov AA: The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection. Antiviral Res. 2019 Nov;171:104597. doi: 10.1016/j.antiviral.2019.104597. Epub 2019 Sep 5. [PubMed:31494195] |
T. P. Sheahan et al.: An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci. Transl. Med.. 4.Pyrc K, Bosch BJ, Berkhout B, Jebbink MF, Dijkman R, Rottier P, van der Hoek L: Inhibition of human coronavirus NL63 infection at early stages of the replication cycle. Antimicrob Agents Chemother. 2006 Jun;50(6):2000-8. doi: 10.1128/AAC.01598-05. [PubMed:16723558] |
Sledziewska E, Janion C: Mutagenic specificity of N4-hydroxycytidine. Mutat Res. 1980 Mar;70(1):11-6. doi: 10.1016/0027-5107(80)90053-6. [PubMed:7366595] |
Toots M, Yoon JJ, Cox RM, Hart M, Sticher ZM, Makhsous N, Plesker R, Barrena AH, Reddy PG, Mitchell DG, Shean RC, Bluemling GR, Kolykhalov AA, Greninger AL, Natchus MG, Painter GR, Plemper RK: Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Sci Transl Med. 2019 Oct 23;11(515). pii: 11/515/eaax5866. doi: 10.1126/scitranslmed.aax5866. [PubMed:31645453] |
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻

怎么做细胞爬片免疫组化染色实验
细胞爬片免疫组化染色,是通过细胞爬片是让玻片浸在细胞培养基内,细胞在玻片上生长,主要用于组织学,免疫组织化学...
2020/7/20 22:04:33

提取病毒RNA的实验方法
提取病毒RNA方法分别有:异硫氰酸胍的提取病毒RNA方法、TRIzol LS提取法、Trizol法提取法等等...
2020/7/22 20:29:26

如何选BSA(牛血清白蛋白)
如何选BSA(牛血清白蛋白):牛血清白蛋白(BSA)有多种形式,如何选择适合自己的牛血清白蛋白(BSA)是一...
2023/2/14 13:09:18

牛血清白蛋白(BSA)常见问题
牛血清白蛋白(BSA)常见问题:牛血清白蛋白(BSA)在实验室中是通用的,可用于蛋白质印迹、细胞组织培养、P...
2022/10/19 9:39:51

pubmed使用方法(技巧)
pubmed使用方法(技巧):PubMed是一个关于医学问题的学术文章和书籍的数据库。因为它是一份学术期刊,...
2022/10/18 18:06:07

BSA(牛血清白蛋白)
BSA(牛血清白蛋白):牛血清白蛋白(BSA)是一种球状蛋白质,牛血清白蛋白(BSA)是发现于牛血浆中的主要...
2022/10/18 16:48:12

冻干培养细菌的方法
冻干培养细菌的方法:冷冻干燥,也称为冻干或冷冻干燥,是在产品冷冻后除去水分并将其置于真空中的过程。这使得冰可...
2022/10/16 8:27:31

革兰氏染色应用(原理,方法,步骤,优缺点)
微生物中的革兰氏染色应用:革兰氏染色是一种差异染色方法,用于根据细菌细胞壁的特性将细菌分为两组(革兰氏阳性和...
2022/10/16 8:10:57

支原体去除剂的使用方法,工作浓度,对细胞有影响吗?
支原体去除剂的使用方法,工作浓度,对细胞有影响吗?将支原体清除剂添加到被支原体污染的细胞培养物中,浓度建议为...
2022/10/13 9:24:46

DNA和染色体之间的差别
DNA和染色体之间的差别:DNA和染色体的关键区别在于其结构的组织。DNA是由脱氧核糖核苷酸组成的双链螺旋聚...
2022/10/10 12:49:53